MCAM and LAMA4 Are Highly Enriched in Tumor Blood Vessels of Renal Cell Carcinoma and Predict Patient Outcome

Overview

Journal Cancer Res

Specialty Oncology

Date 2016 Feb 28

PMID 26921326

Citations 41

Authors

Joseph W Wragg

Jonathan P Finnity

Jane A Anderson

Henry J M Ferguson

Emilio Porfiri

Rupesh I Bhatt

Paul G Murray

Victoria L Heath

Roy Bicknell

Affiliations

Soon will be listed here.

Abstract

The structure and molecular signature of tumor-associated vasculature are distinct from those of the host tissue, offering an opportunity to selectively target the tumor blood vessels. To identify tumor-specific endothelial markers, we performed a microarray on tumor-associated and nonmalignant endothelium collected from patients with renal cell carcinoma (RCC), colorectal carcinoma, or colorectal liver metastasis. We identified a panel of genes consistently upregulated by tumor blood vessels, of which melanoma cell adhesion molecule (MCAM) and its extracellular matrix interaction partner laminin alpha 4 (LAMA4) emerged as the most consistently expressed genes. This result was subsequently confirmed by immunohistochemical analysis of MCAM and LAMA4 expression in RCC and colorectal carcinoma blood vessels. Strong MCAM and LAMA4 expression was also shown to predict poor survival in RCC, but not in colorectal carcinoma. Notably, MCAM and LAMA4 were enhanced in locally advanced tumors as well as both the primary tumor and secondary metastases. Expression analysis in 18 different cancers and matched healthy tissues revealed vascular MCAM as highly specific in RCC, where it was induced strongly by VEGF, which is highly abundant in this disease. Lastly, MCAM monoclonal antibodies specifically localized to vessels in a murine model of RCC, offering an opportunity for endothelial-specific targeting of anticancer agents. Overall, our findings highlight MCAM and LAMA4 as prime candidates for RCC prognosis and therapeutic targeting. Cancer Res; 76(8); 2314-26. ©2016 AACR.

Citing Articles

New Anti-Angiogenic Therapy for Glioblastoma With the Anti-Depressant Sertraline.

Tsuboi N, Otani Y, Uneda A, Ishida J, Suruga Y, Matsumoto Y Cancer Med. 2024; 13(20):e70288.

PMID: 39440923 PMC: 11497491. DOI: 10.1002/cam4.70288.

Matrisome proteomics reveals novel mediators of muscle remodeling with aerobic exercise training.

Pattamaprapanont P, Cooney E, MacDonald T, Paulo J, Pan H, Dreyfuss J Matrix Biol Plus. 2024; 23:100159.

PMID: 39220302 PMC: 11363848. DOI: 10.1016/j.mbplus.2024.100159.

Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer.

Hoffmann H, Wartenberg M, Vorlova S, Karl-Scholler F, Kallius M, Reinhardt O Oncogene. 2024; 43(35):2661-2676.

PMID: 39095583 PMC: 11347376. DOI: 10.1038/s41388-024-03113-1.

Molecular mechanisms and clinical relevance of endothelial cell cross-talk in clear cell renal cell carcinoma.

Sjoberg E Ups J Med Sci. 2024; 129.

PMID: 38863726 PMC: 11165252. DOI: 10.48101/ujms.v129.10632.

CD146-targeted nuclear medicine imaging in cancer: state of the art.

Yang Q, Huang W, Hsu J, Song L, Sun X, Li C View (Beijing). 2023; 4(5).

PMID: 38076327 PMC: 10703309. DOI: 10.1002/VIW.20220085.

References

Colognato H, Yurchenco P . Form and function: the laminin family of heterotrimers. Dev Dyn. 2000; 218(2):213-34. DOI: 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R. View

Ross J, Huh D, Noble L, Tavazoie S . Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol. 2015; 17(5):651-64. PMC: 4609531. DOI: 10.1038/ncb3148. View

Bardin N, Anfosso F, Masse J, Cramer E, Sabatier F, Le Bivic A . Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001; 98(13):3677-84. DOI: 10.1182/blood.v98.13.3677. View

Gonzalez A, Gonzales M, Herron G, Nagavarapu U, Hopkinson S, Tsuruta D . Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo. Proc Natl Acad Sci U S A. 2002; 99(25):16075-80. PMC: 138567. DOI: 10.1073/pnas.252649399. View

Yoshioka S, Fujiwara H, Higuchi T, Yamada S, Maeda M, Fujii S . Melanoma cell adhesion molecule (MCAM/CD146) is expressed on human luteinizing granulosa cells: enhancement of its expression by hCG, interleukin-1 and tumour necrosis factor-alpha. Mol Hum Reprod. 2003; 9(6):311-9. DOI: 10.1093/molehr/gag042. View

Yan X, Lin Y, Yang D, Shen Y, Yuan M, Zhang Z . A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood. 2003; 102(1):184-91. DOI: 10.1182/blood-2002-04-1004. View

Thorpe P . Vascular targeting agents as cancer therapeutics. Clin Cancer Res. 2004; 10(2):415-27. DOI: 10.1158/1078-0432.ccr-0642-03. View

Wu G, Peng Q, Fu P, Wang S, Chiang C, Dillehay D . Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene. 2004; 327(2):201-13. DOI: 10.1016/j.gene.2003.11.018. View

Siemann D, Chaplin D, Horsman M . Vascular-targeting therapies for treatment of malignant disease. Cancer. 2004; 100(12):2491-9. DOI: 10.1002/cncr.20299. View

10.

Miner J, Yurchenco P . Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol. 2004; 20:255-84. DOI: 10.1146/annurev.cellbio.20.010403.094555. View

11.

Lehmann J, Riethmuller G, Johnson J . MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci U S A. 1989; 86(24):9891-5. PMC: 298608. DOI: 10.1073/pnas.86.24.9891. View

12.

Burrows F, Thorpe P . Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci U S A. 1993; 90(19):8996-9000. PMC: 47488. DOI: 10.1073/pnas.90.19.8996. View

13.

Fisher C, Powers E, Petzold G, Poorman R, Mitchell M . Interstitial collagenase is required for angiogenesis in vitro. Dev Biol. 1994; 162(2):499-510. DOI: 10.1006/dbio.1994.1104. View

14.

Jendraschak E, Sage E . Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin Cancer Biol. 1996; 7(3):139-46. DOI: 10.1006/scbi.1996.0019. View

15.

Soker S, Takashima S, Miao H, Neufeld G, Klagsbrun M . Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998; 92(6):735-45. DOI: 10.1016/s0092-8674(00)81402-6. View

16.

Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T . Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun. 2004; 325(2):395-400. DOI: 10.1016/j.bbrc.2004.10.042. View

17.

Cohen H, McGovern F . Renal-cell carcinoma. N Engl J Med. 2005; 353(23):2477-90. DOI: 10.1056/NEJMra043172. View

18.

Hajitou A, Pasqualini R, Arap W . Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med. 2006; 16(3):80-8. PMC: 7172921. DOI: 10.1016/j.tcm.2006.01.003. View

19.

Brack S, Silacci M, Birchler M, Neri D . Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res. 2006; 12(10):3200-8. DOI: 10.1158/1078-0432.CCR-05-2804. View

20.

Verheul H, Hammers H, van Erp K, Wei Y, Sanni T, Salumbides B . Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model. Clin Cancer Res. 2007; 13(14):4201-8. DOI: 10.1158/1078-0432.CCR-06-2553. View